Journal metric profile

CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 2.600 2025 metric year
5-Year Impact Factor 2.400 Longer citation window
JCR Quartile Q3 Subject-category quartile
JCR Category Rank 177/352 Recorded category rank

CURRENT PHARMACEUTICAL BIOTECHNOLOGY JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

CURRENT PHARMACEUTICAL BIOTECHNOLOGY metric snapshot

CURRENT PHARMACEUTICAL BIOTECHNOLOGY has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is BENTHAM SCIENCE PUBL LTD. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 2.600. The five-year Journal Impact Factor is 2.400, giving a second citation window for comparison. The journal is recorded in quartile Q3 for its listed JCR category.

Category position and quartile

The recorded JCR category position is 177 out of 352 journals. Based on that rank position, the journal sits within approximately the top 50% of the listed category. Its listed quartile is Q3. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (2.400) is 0.200 points lower than the standard Journal Impact Factor (2.600). Without journal self-citations, the Impact Factor is 2.500, a difference of 0.100 points from the listed standard value. The Journal Citation Indicator (JCI) is recorded as 0.460. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for CURRENT PHARMACEUTICAL BIOTECHNOLOGY lists total cites: 4,758; total articles: 102; citable items: 279. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 7.8 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 7.3 years, indicating the median age of references used by the journal’s articles.

Identifiers and verification

CURRENT PHARMACEUTICAL BIOTECHNOLOGY is identified in this directory by print ISSN 1389-2010 and electronic ISSN 1873-4316. The publisher is recorded as BENTHAM SCIENCE PUBL LTD. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal nameCURRENT PHARMACEUTICAL BIOTECHNOLOGY
Abbreviated journalCURR PHARM BIOTECHNO
PublisherBENTHAM SCIENCE PUBL LTD
Metric year2025
Overall rank6,008
ISSN1389-2010
eISSN1873-4316
Total cites4,758
Total articles102
Citable items279
Cited half-life7.8 years
Citing half-life7.3 years
JCR-based Journal Impact Factor2.600
5-Year Impact Factor2.400
Impact Factor without journal self-cites2.500
Journal Citation Indicator0.460
JCR Impact Factor quartileQ3
JCR category rank177/352
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of CURRENT PHARMACEUTICAL BIOTECHNOLOGY?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for CURRENT PHARMACEUTICAL BIOTECHNOLOGY is 2.600 for the 2025 metric year.

What are the JCR quartile and category rank of CURRENT PHARMACEUTICAL BIOTECHNOLOGY?

CURRENT PHARMACEUTICAL BIOTECHNOLOGY is listed with quartile Q3 and category rank 177/352. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of CURRENT PHARMACEUTICAL BIOTECHNOLOGY?

The five-year Journal Impact Factor recorded for CURRENT PHARMACEUTICAL BIOTECHNOLOGY is 2.400. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes CURRENT PHARMACEUTICAL BIOTECHNOLOGY?

CURRENT PHARMACEUTICAL BIOTECHNOLOGY is listed in this directory as being published by BENTHAM SCIENCE PUBL LTD.

Additional records from the same publisher or with a similar listed JCR Impact Factor.